Cellular Biomedicine Group Overview

Cellular Biomedicine Group Research & Development

Research & Development expenses for CBMG.

Quarterly R&D Expenses

$12.61M

↓ 3.92% YoY

As of Sep 30, 2020

Annual R&D Expenses (TTM)

$39.97M

↑ 16.46% YoY

Trailing 12 months ending Sep 30, 2020

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin